Streptozocin Zanosar

Streptozocin Zanosar

This chemotherapy and cancer drugs article is about Streptozocin (Zanosar) which is a chemotherapy drug  used to treat pancreatic cancer.  It is not licensed in the UK but is used in research trials.  It belongs to a group of chemotherapy drugs called nitrosoureas.  They work by sticking to one of the cancer cells DNA strands so the cell cant divide. Streptozocin is administered intravenously.

Side effects can include: deep fatigue that can carry on after treatment ends, nausea and vomiting, temporary kidney and liver changes, increased risk of infection, bruising and bleeding, blood sugar changes, mouth ulcers and diarrhoea.

Approved by

the Medical Board. 

Click Here







Other articles that you may find interesting are:

  1. A diet for Chemotherapy
  2. Immunotherapy overview
  3. A to Z Guide to Complementary Therapies

Go to: Return to the CANCERactive drug list


Learn about your cancer drugs.
CancerAcitve Logo
Subscribe (Free e-Newsletter)

Join Our

Join Our Newsletter Signup today for free and be the first to get notified on new updates.